EverSource Wealth Advisors »

Atrium Therapeutics shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $53 4 13.33

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Apple Stock (AAPL)
iShares Gold Trust ETF Etf (IAU)
Nvidia Corporation Stock (NVDA)
Vanguard Short-term Bond Etf Etf (BSV)
State Street Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Total International Bond Etf Etf (BNDX)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for EverSource Wealth Advisors

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics